Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report. Respirology. 2017;22(3):575-601.

Rootmensen GN, van Keimpema AR, Looysen EE, van der Schaaf L, de Haan RJ, Jansen HM. The effects of additional care by a pulmonary nurse for asthma and COPD patients at a respiratory outpatient clinic: results from a double blind, randomized clinical trial. Patient Education and Counseling. 2008;70(2):179-86.

Hobbs B, Zhou J, Castaldi P, Hawrylkiewicz I, Sliwinski P, Yim J, et al. Variants Tagging Serpina1 And Il27 Show Significant Association With COPD In A Meta-Analysis With Over 16,700 Subjects. Medico. 2016;8(9):10.

Muro S, Tabara Y, Matsumoto H, Setoh K, Kawaguchi T, Takahashi M, et al. Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study. Medicine. 2016;95(15):e3371.

Layani-Milon M-P, Gras I, Valette M, Luciani J, Stagnara J, Aymard M, et al. Incidence of Upper Respiratory TractMycoplasma pneumoniae Infections among Outpatients in Rhône-Alpes, France, during Five Successive Winter Periods. Journal of clinical microbiology. 1999;37(6):1721-6.

Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clinical microbiology reviews. 2004;17(4):697-728.

Lieberman D, Lieberman D, Ben-Yaakov M, Shmarkov O, Gelfer Y, Varshavsky R, et al. Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD. Diagnostic Microbiology and Infectious Disease. 2002;44(1):1-6.

Meloni F, Paschetto E, Mangiarotti P, Crepaldi M, Morosini M, Bulgheroni A, et al. Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations. Journal of chemotherapy. 2004;16(1):70-6.

Papaetis G, Anastasakou E, Tselou T, Sotiriou A, Rarra V, Roussou P, et al. Serological evidence of Mycoplasma pneumoniae infection in patients with acute exacerbation of COPD: analysis of 100 hospitalizations. Advances in medical sciences. 2010;55(2):235-41.

Diederen BM, Van der Valk P, Kluytmans JA, Peeters MF, Hendrix R. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. European Respiratory Journal. 2007;30(2):240-4.

Varma-Basil M, Dwivedi SK, Kumar K, Pathak R, Rastogi R, Thukral S, et al. Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease. Journal of medical microbiology. 2009;58(3):322-6.

Varma-Basil M, Dwivedi SK, Kumar K, Pathak R, Rastogi R, Thukral SS, et al. Role of Mycoplasma pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease. J Med Microbiol. 2009;58(Pt 3):322-6.